[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Lung Cancer Diagnostic Tests Market Report 2018

March 2018 | 106 pages | ID: U0DB620E4C4QEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Lung Cancer Diagnostic Tests market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Lung Cancer Diagnostic Tests in these regions, from 2013 to 2025 (forecast).
United States Lung Cancer Diagnostic Tests market competition by top manufacturers/players, with Lung Cancer Diagnostic Tests sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Advpharma Inc
  • AIT Austrian Institute of Technology GmbH
  • Courtagen Life Sciences Inc
  • DiagnoCure Inc. (Inactive)
  • BioMark Diagnostics Inc.
  • BioMarker Strategies LLC
  • Emory University
  • Epigenomics AG
  • GlycoZym
  • HalioDx SAS
  • Louisville Bioscience, Inc.
  • Mayo Clinic US
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Immunoassays
  • Flow Cytometry
  • Rapid Tests
  • Molecular Assays
  • Tissue Arrays
  • Circulating Tumor Cells
  • Pharmacodiagnostics
  • Biomarkers
  • Other Diagnostics Methods
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Precision Medicine
  • Personalized Medicine
  • Cancer Monitoring
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Lung Cancer Diagnostic Tests Market Report 2018

1 LUNG CANCER DIAGNOSTIC TESTS OVERVIEW

1.1 Product Overview and Scope of Lung Cancer Diagnostic Tests
1.2 Classification of Lung Cancer Diagnostic Tests by Product Category
  1.2.1 United States Lung Cancer Diagnostic Tests Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Lung Cancer Diagnostic Tests Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Immunoassays
  1.2.4 Flow Cytometry
  1.2.5 Rapid Tests
  1.2.6 Molecular Assays
  1.2.7 Tissue Arrays
  1.2.8 Circulating Tumor Cells
  1.2.9 Pharmacodiagnostics
  1.2.10 Biomarkers
  1.2.11 Other Diagnostics Methods
1.3 United States Lung Cancer Diagnostic Tests Market by Application/End Users
  1.3.1 United States Lung Cancer Diagnostic Tests Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Precision Medicine
  1.3.3 Personalized Medicine
  1.3.4 Cancer Monitoring
1.4 United States Lung Cancer Diagnostic Tests Market by Region
  1.4.1 United States Lung Cancer Diagnostic Tests Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Lung Cancer Diagnostic Tests Status and Prospect (2013-2025)
  1.4.3 Southwest Lung Cancer Diagnostic Tests Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Lung Cancer Diagnostic Tests Status and Prospect (2013-2025)
  1.4.5 New England Lung Cancer Diagnostic Tests Status and Prospect (2013-2025)
  1.4.6 The South Lung Cancer Diagnostic Tests Status and Prospect (2013-2025)
  1.4.7 The Midwest Lung Cancer Diagnostic Tests Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Lung Cancer Diagnostic Tests (2013-2025)
  1.5.1 United States Lung Cancer Diagnostic Tests Sales and Growth Rate (2013-2025)
  1.5.2 United States Lung Cancer Diagnostic Tests Revenue and Growth Rate (2013-2025)

2 UNITED STATES LUNG CANCER DIAGNOSTIC TESTS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Lung Cancer Diagnostic Tests Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Lung Cancer Diagnostic Tests Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Lung Cancer Diagnostic Tests Average Price by Players/Suppliers (2013-2018)
2.4 United States Lung Cancer Diagnostic Tests Market Competitive Situation and Trends
  2.4.1 United States Lung Cancer Diagnostic Tests Market Concentration Rate
  2.4.2 United States Lung Cancer Diagnostic Tests Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Lung Cancer Diagnostic Tests Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES LUNG CANCER DIAGNOSTIC TESTS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Lung Cancer Diagnostic Tests Sales and Market Share by Region (2013-2018)
3.2 United States Lung Cancer Diagnostic Tests Revenue and Market Share by Region (2013-2018)
3.3 United States Lung Cancer Diagnostic Tests Price by Region (2013-2018)

4 UNITED STATES LUNG CANCER DIAGNOSTIC TESTS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Lung Cancer Diagnostic Tests Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Lung Cancer Diagnostic Tests Revenue and Market Share by Type (2013-2018)
4.3 United States Lung Cancer Diagnostic Tests Price by Type (2013-2018)
4.4 United States Lung Cancer Diagnostic Tests Sales Growth Rate by Type (2013-2018)

5 UNITED STATES LUNG CANCER DIAGNOSTIC TESTS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Lung Cancer Diagnostic Tests Sales and Market Share by Application (2013-2018)
5.2 United States Lung Cancer Diagnostic Tests Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES LUNG CANCER DIAGNOSTIC TESTS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Advpharma Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 AIT Austrian Institute of Technology GmbH
  6.2.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Courtagen Life Sciences Inc
  6.3.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 DiagnoCure Inc. (Inactive)
  6.4.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 BioMark Diagnostics Inc.
  6.5.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 BioMarker Strategies LLC
  6.6.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Emory University
  6.7.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Emory University Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Epigenomics AG
  6.8.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 GlycoZym
  6.9.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 GlycoZym Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 HalioDx SAS
  6.10.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Louisville Bioscience, Inc.
6.12 Mayo Clinic US

7 LUNG CANCER DIAGNOSTIC TESTS MANUFACTURING COST ANALYSIS

7.1 Lung Cancer Diagnostic Tests Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Lung Cancer Diagnostic Tests

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Lung Cancer Diagnostic Tests Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Lung Cancer Diagnostic Tests Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES LUNG CANCER DIAGNOSTIC TESTS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Lung Cancer Diagnostic Tests Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Lung Cancer Diagnostic Tests Sales Volume Forecast by Type (2018-2025)
11.3 United States Lung Cancer Diagnostic Tests Sales Volume Forecast by Application (2018-2025)
11.4 United States Lung Cancer Diagnostic Tests Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Lung Cancer Diagnostic Tests
Figure United States Lung Cancer Diagnostic Tests Market Size (K Units) by Type (2013-2025)
Figure United States Lung Cancer Diagnostic Tests Sales Volume Market Share by Type (Product Category) in 2017
Figure Immunoassays Product Picture
Figure Flow Cytometry Product Picture
Figure Rapid Tests Product Picture
Figure Molecular Assays Product Picture
Figure Tissue Arrays Product Picture
Figure Circulating Tumor Cells Product Picture
Figure Pharmacodiagnostics Product Picture
Figure Biomarkers Product Picture
Figure Other Diagnostics Methods Product Picture
Figure United States Lung Cancer Diagnostic Tests Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Lung Cancer Diagnostic Tests by Application in 2017
Figure Precision Medicine Examples
Table Key Downstream Customer in Precision Medicine
Figure Personalized Medicine Examples
Table Key Downstream Customer in Personalized Medicine
Figure Cancer Monitoring Examples
Table Key Downstream Customer in Cancer Monitoring
Figure United States Lung Cancer Diagnostic Tests Market Size (Million USD) by Region (2013-2025)
Figure The West Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (2013-2025)
Figure United States Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Lung Cancer Diagnostic Tests Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Lung Cancer Diagnostic Tests Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Lung Cancer Diagnostic Tests Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Lung Cancer Diagnostic Tests Sales Share by Players/Suppliers
Figure 2017 United States Lung Cancer Diagnostic Tests Sales Share by Players/Suppliers
Figure United States Lung Cancer Diagnostic Tests Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Lung Cancer Diagnostic Tests Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Lung Cancer Diagnostic Tests Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Lung Cancer Diagnostic Tests Revenue Share by Players/Suppliers
Figure 2017 United States Lung Cancer Diagnostic Tests Revenue Share by Players/Suppliers
Table United States Market Lung Cancer Diagnostic Tests Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Lung Cancer Diagnostic Tests Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Lung Cancer Diagnostic Tests Market Share of Top 3 Players/Suppliers
Figure United States Lung Cancer Diagnostic Tests Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Lung Cancer Diagnostic Tests Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Lung Cancer Diagnostic Tests Product Category
Table United States Lung Cancer Diagnostic Tests Sales (K Units) by Region (2013-2018)
Table United States Lung Cancer Diagnostic Tests Sales Share by Region (2013-2018)
Figure United States Lung Cancer Diagnostic Tests Sales Share by Region (2013-2018)
Figure United States Lung Cancer Diagnostic Tests Sales Market Share by Region in 2017
Table United States Lung Cancer Diagnostic Tests Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Lung Cancer Diagnostic Tests Revenue Share by Region (2013-2018)
Figure United States Lung Cancer Diagnostic Tests Revenue Market Share by Region (2013-2018)
Figure United States Lung Cancer Diagnostic Tests Revenue Market Share by Region in 2017
Table United States Lung Cancer Diagnostic Tests Price (USD/Unit) by Region (2013-2018)
Table United States Lung Cancer Diagnostic Tests Sales (K Units) by Type (2013-2018)
Table United States Lung Cancer Diagnostic Tests Sales Share by Type (2013-2018)
Figure United States Lung Cancer Diagnostic Tests Sales Share by Type (2013-2018)
Figure United States Lung Cancer Diagnostic Tests Sales Market Share by Type in 2017
Table United States Lung Cancer Diagnostic Tests Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Lung Cancer Diagnostic Tests Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Lung Cancer Diagnostic Tests by Type (2013-2018)
Figure Revenue Market Share of Lung Cancer Diagnostic Tests by Type in 2017
Table United States Lung Cancer Diagnostic Tests Price (USD/Unit) by Types (2013-2018)
Figure United States Lung Cancer Diagnostic Tests Sales Growth Rate by Type (2013-2018)
Table United States Lung Cancer Diagnostic Tests Sales (K Units) by Application (2013-2018)
Table United States Lung Cancer Diagnostic Tests Sales Market Share by Application (2013-2018)
Figure United States Lung Cancer Diagnostic Tests Sales Market Share by Application (2013-2018)
Figure United States Lung Cancer Diagnostic Tests Sales Market Share by Application in 2017
Table United States Lung Cancer Diagnostic Tests Sales Growth Rate by Application (2013-2018)
Figure United States Lung Cancer Diagnostic Tests Sales Growth Rate by Application (2013-2018)
Table Advpharma Inc Basic Information List
Table Advpharma Inc Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Advpharma Inc Lung Cancer Diagnostic Tests Sales Growth Rate (2013-2018)
Figure Advpharma Inc Lung Cancer Diagnostic Tests Sales Market Share in United States (2013-2018)
Figure Advpharma Inc Lung Cancer Diagnostic Tests Revenue Market Share in United States (2013-2018)
Table AIT Austrian Institute of Technology GmbH Basic Information List
Table AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Sales Growth Rate (2013-2018)
Figure AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Sales Market Share in United States (2013-2018)
Figure AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Revenue Market Share in United States (2013-2018)
Table Courtagen Life Sciences Inc Basic Information List
Table Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales Growth Rate (2013-2018)
Figure Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales Market Share in United States (2013-2018)
Figure Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Revenue Market Share in United States (2013-2018)
Table DiagnoCure Inc. (Inactive) Basic Information List
Table DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Sales Growth Rate (2013-2018)
Figure DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Sales Market Share in United States (2013-2018)
Figure DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Revenue Market Share in United States (2013-2018)
Table BioMark Diagnostics Inc. Basic Information List
Table BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Sales Growth Rate (2013-2018)
Figure BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Sales Market Share in United States (2013-2018)
Figure BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Revenue Market Share in United States (2013-2018)
Table BioMarker Strategies LLC Basic Information List
Table BioMarker Strategies LLC Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure BioMarker Strategies LLC Lung Cancer Diagnostic Tests Sales Growth Rate (2013-2018)
Figure BioMarker Strategies LLC Lung Cancer Diagnostic Tests Sales Market Share in United States (2013-2018)
Figure BioMarker Strategies LLC Lung Cancer Diagnostic Tests Revenue Market Share in United States (2013-2018)
Table Emory University Basic Information List
Table Emory University Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Emory University Lung Cancer Diagnostic Tests Sales Growth Rate (2013-2018)
Figure Emory University Lung Cancer Diagnostic Tests Sales Market Share in United States (2013-2018)
Figure Emory University Lung Cancer Diagnostic Tests Revenue Market Share in United States (2013-2018)
Table Epigenomics AG Basic Information List
Table Epigenomics AG Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Epigenomics AG Lung Cancer Diagnostic Tests Sales Growth Rate (2013-2018)
Figure Epigenomics AG Lung Cancer Diagnostic Tests Sales Market Share in United States (2013-2018)
Figure Epigenomics AG Lung Cancer Diagnostic Tests Revenue Market Share in United States (2013-2018)
Table GlycoZym Basic Information List
Table GlycoZym Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GlycoZym Lung Cancer Diagnostic Tests Sales Growth Rate (2013-2018)
Figure GlycoZym Lung Cancer Diagnostic Tests Sales Market Share in United States (2013-2018)
Figure GlycoZym Lung Cancer Diagnostic Tests Revenue Market Share in United States (2013-2018)
Table HalioDx SAS Basic Information List
Table HalioDx SAS Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure HalioDx SAS Lung Cancer Diagnostic Tests Sales Growth Rate (2013-2018)
Figure HalioDx SAS Lung Cancer Diagnostic Tests Sales Market Share in United States (2013-2018)
Figure HalioDx SAS Lung Cancer Diagnostic Tests Revenue Market Share in United States (2013-2018)
Table Louisville Bioscience, Inc. Basic Information List
Table Mayo Clinic US Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Lung Cancer Diagnostic Tests
Figure Manufacturing Process Analysis of Lung Cancer Diagnostic Tests
Figure Lung Cancer Diagnostic Tests Industrial Chain Analysis
Table Raw Materials Sources of Lung Cancer Diagnostic Tests Major Players/Suppliers in 2017
Table Major Buyers of Lung Cancer Diagnostic Tests
Table Distributors/Traders List
Figure United States Lung Cancer Diagnostic Tests Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Lung Cancer Diagnostic Tests Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Lung Cancer Diagnostic Tests Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Lung Cancer Diagnostic Tests Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Lung Cancer Diagnostic Tests Sales Volume (K Units) Forecast by Type in 2025
Table United States Lung Cancer Diagnostic Tests Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Lung Cancer Diagnostic Tests Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Lung Cancer Diagnostic Tests Sales Volume (K Units) Forecast by Application in 2025
Table United States Lung Cancer Diagnostic Tests Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Lung Cancer Diagnostic Tests Sales Volume Share Forecast by Region (2018-2025)
Figure United States Lung Cancer Diagnostic Tests Sales Volume Share Forecast by Region (2018-2025)
Figure United States Lung Cancer Diagnostic Tests Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories